<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Secondary endpoints included number of visits for mobilization purposes and number of days receiving mobilizing agents, number and duration of apheresis sessions, time from apheresis to transplant, transplant outcome, attainment of CD34+ target and days until target was met, and adverse events during mobilization.</p>
